These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1679916)

  • 21. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes.
    Chung HS; Shin DH; Birt CM; Kim C; Lee D; Levin DS; Hakimzadeh R; Juzych MS
    Ophthalmology; 1997 Nov; 104(11):1921-5. PubMed ID: 9373127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apraclonidine prophylaxis for postcycloplegic intraocular pressure spikes.
    Hill RA; Minckler DS; Lee M; Heuer DK; Baerveldt G; Martone JF
    Ophthalmology; 1991 Jul; 98(7):1083-6. PubMed ID: 1679917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term ocular hypotensive effect of levobunolol: results of a one-year study.
    Ober M; Scharrer A; David R; Biedner BZ; Novack GD; Lue JC; Robins DS; Duzman E
    Br J Ophthalmol; 1985 Aug; 69(8):593-9. PubMed ID: 3893528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
    Barnes SD; Campagna JA; Dirks MS; Doe EA
    Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?
    Parrow KA; Hong YJ; Shin DH; Shi DX; McCarty B
    Ophthalmology; 1989 Sep; 96(9):1338-41; discussion 1341-2. PubMed ID: 2571114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Questions concerning the role of apraclonidine in the management of glaucoma.
    Robin AL
    Arch Ophthalmol; 1995 Jun; 113(6):712-4. PubMed ID: 7786208
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of apraclonidine hydrochloride on the attack of Posner-Schlossman syndrome.
    Hong C; Song KY
    Korean J Ophthalmol; 1993 Jun; 7(1):28-33. PubMed ID: 7901442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
    Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
    Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing intraocular pressure increase after phacoemulsification and the role of perioperative apraclonidine.
    Kasetti SR; Desai SP; Sivakumar S; Sunderraj P
    J Cataract Refract Surg; 2002 Dec; 28(12):2177-80. PubMed ID: 12498856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
    Morrison JC; Robin AL
    Ophthalmology; 1989 Jan; 96(1):3-7. PubMed ID: 2645550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma.
    Gramer E; Busche S; Kampik A; Parsons D
    Graefes Arch Clin Exp Ophthalmol; 1995 Jan; 233(1):13-20. PubMed ID: 7721118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of apraclonidine hydrochloride on acute introacular pressure rise after argon laser iridotomy.
    Hong C; Song KY; Park WH; Sohn YH
    Korean J Ophthalmol; 1991 Jun; 5(1):37-41. PubMed ID: 1682521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levobunolol compared with timolol for the long-term control of elevated intraocular pressure.
    Berson FG; Cohen HB; Foerster RJ; Lass JH; Novack GD; Duzman E
    Arch Ophthalmol; 1985 Mar; 103(3):379-82. PubMed ID: 3883972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME; Robin AL; Cummings HL; Arkin LM
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
    Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.